Mark S. Ordan - 12 Jan 2025 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: MD
Reported as of: 12 Jan 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jan 2025, 17:30:11 UTC
Prior SEC filing: 14 Nov 2024
Next SEC filing: 02 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Mary Ann E. Moore, Attorney-in-Fact

Key filing fact

Mark S. Ordan filed Form 4 for Pediatrix Medical Group, Inc. (MD) on 14 Jan 2025.

Key facts

This page summarizes Mark S. Ordan's Form 4 filing for Pediatrix Medical Group, Inc. (MD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Jan 2025, 17:30.

Change

Previous filing in this sequence was filed on 14 Nov 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MD transaction Derivative

Performance Share Unit

Award

Transaction value: $0
Shares: +640,000
Change %
Price: $0.000000
Shares after: 640,000
Date: 12 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 640,000
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each Performance Share Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both a service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to 125%, 150% and 175% of $13.55 for at least 20 consecutive trading days before the third anniversary of the grant date.